| Small Cell | Adding high-dose, targeted radiation to the usual treatment for locally-advanced, inoperable non-small cell lung cancer | Currently Available for Patients | Download Brochure |
| Small Cell | Can adding radiation to immune therapy help improve survival for people with extensive stage small cell lung cancer? | Currently Available for Patients | Download Brochure |
| Mesothelioma | Testing the addition of targeted radiotherapy to surgery & the usual systemic therapy for malignant pleural mesothelioma | Currently Available for Patients | Download Brochure |
| Small Cell | Chemotherapy with or without the immunotherapy drug atezolizumab in people with limited stage small cell lung cancer | Currently Available for Patients | Download Brochure |
| Other | Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer | Currently Unavailable for Patients | |
| Head and Neck | Comparing a study drug to the usual treatment for people with metastatic HER2-positive salivary gland cancer that cannot be removed by surgery | Currently Available for Patients | Download Brochure |
| Head and Neck | Comparing two cisplatin dosing schedules combined with radiation for patients with advanced head and neck cancer | Currently Available for Patients | Download Brochure |
| Uterine Corpus | A clinical trial for patients with Grade 1 or 2 endometrial cancer which has returned or spread after other treatments | Currently Available for Patients | Download Brochure |
| Uterine Corpus | A clinical trial for patients diagnosed with HER2-positive Uterine Cancer | Currently Available for Patients | Download Brochure |
| Prostate | Can adding radiation therapy to the usually prescribed immune therapy increase the time without your renal cell cancer getting worse or requiring surgery? | Currently Available for Patients | Download Brochure |
| Prostate | Can the drug relugolix combined with radiation improve outcomes for men with limited metastatic “oligometastatic” prostate cancer? | Currently Available for Patients | Download Brochure |
| Prostate | Can gene risk based on the Decipher risk score inform hormonal therapy treatment with radiation for unfavorable intermediate risk prostate cancer? | Currently Available for Patients | Download Brochure |
| Prostate | The PREDICT-RT Trial: Testing Hormone Therapy Treatment to Improve Outcomes for Men with High-risk Prostate Cancer Categorized by Low or High Gene Risk Score | Currently Available for Patients | Download Brochure |
| Prostate | Does adding a study drug to usual therapy after radical prostatectomy delay the spread of prostate cancer? | Currently Available for Patients | Download Brochure |
| Colorectal | CIRCULATE-US: Colon Adjuvant Chemotherapy based on Evaluation of Residual Disease | Currently Available for Patients | Download Brochure |
| Esophageal | Comparing proton to photon radiation therapy for esophageal cancer | Currently Available for Patients | Download Brochure |
| Colorectal | The COBRA Study: Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery | Currently Available for Patients | Download Brochure |
| Colorectal | The COMMIT Study: Comparing the Addition of the Drug Atezolizumab to the Usual Treatment Approach for Colorectal Cancer | Currently Available for Patients | Download Brochure |
| Other | Testing Two Different Radiation Therapy Types to See Which Is Better at Preventing Loss of Memory and Changes in Thinking Ability for People with SCLC that Has Spread to the Brain | Currently Available for Patients | Download Brochure |
| Ovarian | SOROCk: Comparing the Effects of Two Surgical Procedures in Ovarian Cancer Risk Reduction in Women with BRCA1 Mutations | Currently Available for Patients | Download Brochure |
| Colorectal | (FORTE) A study to determine whether a colonoscopy should be done every 5 years or every 10 years in people with 1 or 2 small growths (polyps) removed from their colon | Currently Available for Patients | Download Brochure |
| Breast | Testing the usual treatment of radiation therapy and HER2-targeted therapy to HER2-targeted therapy alone for low-risk HER2-positive breast cancer | Currently Available for Patients | Download Brochure |
| Breast | The DEBRA Trial: De-escalating Breast Radiation After Lumpectomy for Low Risk, Estrogen Receptor Positive, Breast Cancer
| Currently Available for Patients | Download Brochure |
| Brain Mets | Comparing the addition of radiation either before or after surgery for patients with brain metastases | Currently Available for Patients | Download Brochure |
| Malignant Glioma | Can a Second Chemotherapy Drug in Addition to Standard Radiation and Temozolomide Extend Your Life or Prevent the Growth and Spread of Your Brain Tumor? | Currently Available for Patients | Download Brochure |
| Multiple | Testing the use of the combination of selumetinib and olaparib or selumetinib alone targeted treatment for RAS pathway mutant recurrent or persistent ovarian and endometrial cancers | Currently Available for Patients | Download Brochure |
| Breast | Testing the use of fulvestrant and binimetinib targeted treatment for NF1 mutation in hormone receptor-positive metastatic breast cancer | Currently Available for Patients | Download Brochure |